Contact
searchSearch
HMP Global

Peripheral Arterial Disease Topic Center

Features

Original Research
Temporary Occlusion Embolectomy: A Cost-Effective Approach to Distal Embolic Protection in Peripheral Artery Disease
03/18/2026
Tom Davis, MD; Peter Dovgan, MD; Eric J. Dippel, MD
This retrospective observational case series evaluated embolic debris retrieval and procedural feasibility of temporary occlusion embolectomy during complex peripheral vascular interventions.
This retrospective observational case series evaluated embolic debris retrieval and procedural feasibility of temporary occlusion embolectomy during complex peripheral vascular interventions.
This retrospective observational...
03/18/2026
Vascular Disease Management
Clinical Editor's Corner
Expanding the Role of Embolic Protection in Peripheral Arterial Interventions
03/17/2026
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
Dr Walker comments on "Temporary Occlusion Embolectomy: A Cost-Effective Approach to Distal Embolic Protection in Peripheral Artery Disease.”
Dr Walker comments on "Temporary Occlusion Embolectomy: A Cost-Effective Approach to Distal Embolic Protection in Peripheral Artery Disease.”
Dr Walker comments on "Temporary...
03/17/2026
Vascular Disease Management
Dr Marianne Brodmann speaks at ISET 2026
ISET 2026
Benefits of PTX: Insights from the TRUE-PTX Study
03/12/2026
Marianne Brodmann, MD
Dr. Brodmann reviews the results of the TRUE-PTX study, which compared paclitaxel drug-eluting and bare device treatment for PAD using real-world data design.
Dr. Brodmann reviews the results of the TRUE-PTX study, which compared paclitaxel drug-eluting and bare device treatment for PAD using real-world data design.
Dr. Brodmann reviews the results...
03/12/2026
Vascular Disease Management
Interview
Standardizing the Workup: Best Practices for Comprehensive Noninvasive Evaluation in Chronic Limb-Threatening Ischemia
03/11/2026
Srini Tummala, MD
Dr. Srini Tummala outlines the essential components of a high-quality noninvasive vascular assessment for patients with chronic limb-threatening ischemia.
Dr. Srini Tummala outlines the essential components of a high-quality noninvasive vascular assessment for patients with chronic limb-threatening ischemia.
Dr. Srini Tummala outlines the...
03/11/2026
Vascular Disease Management
Dr Andrew Niekamp introduces Drs Siah, N'Dandu, and Nagarsheth
Sponsored Video
Redefining Possibilities in Limb Salvage
03/05/2026
Michael Siah, MD; Zola N'Dandu, MD; Khanjan Nagarsheth, MD, MBA, RPVI
From redefining what “no-option” truly means, to understanding the role of small artery disease and medial arterial calcification in decision-making, this discussion highlights both clinical data and real-world experience with LimFlow.
From redefining what “no-option” truly means, to understanding the role of small artery disease and medial arterial calcification in decision-making, this discussion highlights both clinical data and real-world experience with LimFlow.
From redefining what “no-option”...
03/05/2026
Vascular Disease Management
Dr Elizabeth Genovese
ISET 2026
When Do I Think of a Bypass? Reframing Revascularization Decisions in CLTI
02/11/2026
Elizabeth Genovese, MD, MS, FACS, RPVI
Dr Elizabeth Genovese asked a nuanced question regarding patients with CLTI: when should bypass be considered first—and why?
Dr Elizabeth Genovese asked a nuanced question regarding patients with CLTI: when should bypass be considered first—and why?
Dr Elizabeth Genovese asked a...
02/11/2026
Vascular Disease Management
John Rundback MD
ISET 2026
Vessel Preparation for Tibial Interventions: Why “Just PTA” Is Rarely Enough
02/11/2026
John H. Rundback, MD, FAHA, FSIR
Dr. John H. Rundback challenges the long-standing notion that plain balloon angioplasty alone is sufficient for tibial interventions in patients with chronic limb-threatening ischemia .
Dr. John H. Rundback challenges the long-standing notion that plain balloon angioplasty alone is sufficient for tibial interventions in patients with chronic limb-threatening ischemia .
Dr. John H. Rundback challenges...
02/11/2026
Vascular Disease Management
Dr Andrew Holden
ISET 2026
Bioresorbable Scaffolds in BTK Disease: Where We Are and Where We’re Headed
02/10/2026
Andrew Holden, MBChB
Dr Andrew Holden delivered a comprehensive and forward-looking overview of bioresorbable scaffold technology for BTK disease, with a particular focus on CLTI.
Dr Andrew Holden delivered a comprehensive and forward-looking overview of bioresorbable scaffold technology for BTK disease, with a particular focus on CLTI.
Dr Andrew Holden delivered a...
02/10/2026
Vascular Disease Management
Francesco Liistro, MD
LINC 2026
How to Optimize DCB Results in BTK Arteries: ‘Deep Drug Delivery Is Key!’
01/29/2026
Francesco Liistro, MD
Dr Francesco Liistro shares a pragmatic, mechanics-first approach to DCB therapy in BTK arteries.
Dr Francesco Liistro shares a pragmatic, mechanics-first approach to DCB therapy in BTK arteries.
Dr Francesco Liistro shares a...
01/29/2026
Vascular Disease Management
Dr Tatsuya Nakama
LINC 2026
First-Time Data Revealed From Three-Year PROSPECT MONSTER DCB Registry
01/29/2026
Tatsuya Nakama, MD
Dr Tatsuya Nakama discusses how device design, paclitaxel dose, and meticulous lesion preparation may shape long-term durability in everyday practice.
Dr Tatsuya Nakama discusses how device design, paclitaxel dose, and meticulous lesion preparation may shape long-term durability in everyday practice.
Dr Tatsuya Nakama discusses how...
01/29/2026
Vascular Disease Management
Dr Koen Deloose
LINC 2026
SEPARATE: Could Novel Impedance Sensor be the Best Way to Differentiate Clots in PAD?
01/28/2026
Koen Deloose, MD
An introduction to the SEPARATE feasibility clinical study of the Clotild Smart Guidewire System (Sensome) in peripheral artery disease was presented at LINC on Tuesday afternoon by Dr Koen Deloose.
An introduction to the SEPARATE feasibility clinical study of the Clotild Smart Guidewire System (Sensome) in peripheral artery disease was presented at LINC on Tuesday afternoon by Dr Koen Deloose.
An introduction to the SEPARATE...
01/28/2026
Vascular Disease Management

Videos

Dr Marianne Brodmann speaks at ISET 2026
ISET 2026
Benefits of PTX: Insights from the TRUE-PTX Study
03/12/2026
Marianne Brodmann, MD
Dr. Brodmann reviews the results of the TRUE-PTX study, which compared paclitaxel drug-eluting and bare device treatment for PAD using real-world data design.
Dr. Brodmann reviews the results of the TRUE-PTX study, which compared paclitaxel drug-eluting and bare device treatment for PAD using real-world data design.
Dr. Brodmann reviews the results...
03/12/2026
Vascular Disease Management
Dr Andrew Niekamp introduces Drs Siah, N'Dandu, and Nagarsheth
Sponsored Video
Redefining Possibilities in Limb Salvage
03/05/2026
Michael Siah, MD; Zola N'Dandu, MD; Khanjan Nagarsheth, MD, MBA, RPVI
From redefining what “no-option” truly means, to understanding the role of small artery disease and medial arterial calcification in decision-making, this discussion highlights both clinical data and real-world experience with LimFlow.
From redefining what “no-option” truly means, to understanding the role of small artery disease and medial arterial calcification in decision-making, this discussion highlights both clinical data and real-world experience with LimFlow.
From redefining what “no-option”...
03/05/2026
Vascular Disease Management
McCall Walker, MD
Video Commentary
The Persistent Challenge of Peripheral Arterial Calcium
12/22/2025
McCall Walker, MD
In this video, McCall Walker, MD, discusses the article by Finn et al, "Dealing With Dense Calcium".
In this video, McCall Walker, MD, discusses the article by Finn et al, "Dealing With Dense Calcium".
In this video, McCall Walker,...
12/22/2025
Vascular Disease Management
Interview With Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert
Videos
Prevalence of Atrial Fibrillation Increases Major Adverse Cardiovascular Events, Particularly Heart Failure Hospitalization in Patients With Peripheral Arterial Disease
11/18/2025
Viet Le, PA-C, FACC, FAHA; Isabel Vega
Watch as Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert, discusses his abstract from AHA 2025.
Watch as Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert, discusses his abstract from AHA 2025.
Watch as Viet Le, DMSc, MPAS,...
11/18/2025
EP Lab Digest
Reflow AMP Video
Sponsored Video
Transforming BTK CLTI Treatment With Spur RST: Leading Experts Explore Breakthrough Technology, Clinical Performance, and Real-World Application
10/27/2025
Join a distinguished panel of vascular experts as they discuss the evolving landscape of endovascular therapy for BTK CLTI.
Join a distinguished panel of vascular experts as they discuss the evolving landscape of endovascular therapy for BTK CLTI.
Join a distinguished panel of...
10/27/2025
Vascular Disease Management
Dr Nakama
AMP 2025
One-Year Outcomes of Drug-Eluting Stent vs Drug-Coated Balloon for Femoropopliteal Artery Lesions: The BEASTARS Study Results
10/08/2025
Tatsuya Nakama, MD
In this video recorded at AMP 2025, Tatsuya Nakama, MD, discusses his AMP presentation on 1-year results from the BEASTARS study.
In this video recorded at AMP 2025, Tatsuya Nakama, MD, discusses his AMP presentation on 1-year results from the BEASTARS study.
In this video recorded at AMP...
10/08/2025
Vascular Disease Management
KJ Nagarsheth, MD
Sponsored
Optimizing Outcomes in Complex PAD: Dr. Nagarsheth on DETOUR Integration and Patient Selection
09/23/2025
Khanjan Nagarsheth, MD, MBA, RPVI
Join Dr. KJ Nagarsheth as he reflects on his experience with PTAB Therapy using the DETOUR™ system.
Join Dr. KJ Nagarsheth as he reflects on his experience with PTAB Therapy using the DETOUR™ system.
Join Dr. KJ Nagarsheth as he...
09/23/2025
Vascular Disease Management
Sonya Noor, MD
Sponsored
Transforming Complex PAD Treatment With PTAB Therapy: Dr. Sonya Noor Shares Her Perspective
09/23/2025
Sonya Noor, MD
In this video from AMP 2025, vascular surgeon Dr. Sonya Noor discusses the evolving landscape of treating complex PAD.
In this video from AMP 2025, vascular surgeon Dr. Sonya Noor discusses the evolving landscape of treating complex PAD.
In this video from AMP 2025,...
09/23/2025
Vascular Disease Management
Video
Saving Limbs, Saving Lives, and Reducing Healthcare Costs With DVA
09/19/2025
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
In this video, Clinical Editor Craig Walker, MD, comments on an article from the September issue article entitled “Deep Vein Arterialization for No-Option Chronic Limb-Threatening Ischemia: An Overview of the LimFlow System and CLariTI Study."
In this video, Clinical Editor Craig Walker, MD, comments on an article from the September issue article entitled “Deep Vein Arterialization for No-Option Chronic Limb-Threatening Ischemia: An Overview of the LimFlow System and CLariTI Study."
In this video, Clinical Editor...
09/19/2025
Vascular Disease Management
Mike Watts, MD
AMP 2025
Will AI and Wearables Change the Future of CLTI Therapy?
09/18/2025
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Mike Watts, MD, FSIR, discusses...
09/18/2025
Vascular Disease Management
Screenshot of Dr Walker from his commentary video
Videos
Rethinking Embolic Protection in Peripheral Arterial Interventions
03/18/2026
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
In this video, Dr Walker comments on "Temporary Occlusion Embolectomy: A Cost-Effective Approach to Distal Embolic Protection in Peripheral Artery Disease.”
In this video, Dr Walker comments on "Temporary Occlusion Embolectomy: A Cost-Effective Approach to Distal Embolic Protection in Peripheral Artery Disease.”
In this video, Dr Walker...
03/18/2026
Vascular Disease Management
DDaye headshot
Video
Advancing AI in IO: Improving Research Quality, Clinical Outcomes, and Patient Care
03/13/2026
Dania Daye, MD, PhD
Dr Dania Daye discusses the need for standardized reporting in artificial intelligence (AI) studies and reflects on key themes from her recent keynote at the Society of Interventional Oncology (SIO) conference.
Dr Dania Daye discusses the need for standardized reporting in artificial intelligence (AI) studies and reflects on key themes from her recent keynote at the Society of Interventional Oncology (SIO) conference.
Dr Dania Daye discusses the need...
03/13/2026
Vascular Disease Management
Dr Marianne Brodmann speaks at ISET 2026
ISET 2026
Benefits of PTX: Insights from the TRUE-PTX Study
03/12/2026
Marianne Brodmann, MD
Dr. Brodmann reviews the results of the TRUE-PTX study, which compared paclitaxel drug-eluting and bare device treatment for PAD using real-world data design.
Dr. Brodmann reviews the results of the TRUE-PTX study, which compared paclitaxel drug-eluting and bare device treatment for PAD using real-world data design.
Dr. Brodmann reviews the results...
03/12/2026
Vascular Disease Management
Dr Andrew Niekamp introduces Drs Siah, N'Dandu, and Nagarsheth
Sponsored Video
Redefining Possibilities in Limb Salvage
03/05/2026
Michael Siah, MD; Zola N'Dandu, MD; Khanjan Nagarsheth, MD, MBA, RPVI
From redefining what “no-option” truly means, to understanding the role of small artery disease and medial arterial calcification in decision-making, this discussion highlights both clinical data and real-world experience with LimFlow.
From redefining what “no-option” truly means, to understanding the role of small artery disease and medial arterial calcification in decision-making, this discussion highlights both clinical data and real-world experience with LimFlow.
From redefining what “no-option”...
03/05/2026
Vascular Disease Management
Gustavo Oderich, MD, Robert Rhee, MD, and Sukgu Han, MD
sponsored video
Gustavo Oderich, MD, Robert Rhee, MD, and Sukgu Han, MD Discuss Evolving Treatment Algorithms in AAA Repair of Short, Angulated Necks
02/27/2026
Gustavo S. Oderich, MD; Robert Rhee, MD; Sukgu Han, MD
Three experts share their perspective on the GORE EXCLUDER Conformable AAA Endoprosthesis.
Three experts share their perspective on the GORE EXCLUDER Conformable AAA Endoprosthesis.
Three experts share their...
02/27/2026
Vascular Disease Management
Craig Walker, MD
Video Commentary
Optimizing Safety and Outcomes in Outpatient Practice
01/19/2026
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
In this video, Dr Walker discusses the article by Krishna Jain, MD, "Safety in Office-Based Laboratories and Ambulatory Surgery Centers".
In this video, Dr Walker discusses the article by Krishna Jain, MD, "Safety in Office-Based Laboratories and Ambulatory Surgery Centers".
In this video, Dr Walker...
01/19/2026
Vascular Disease Management
McCall Walker, MD
Video Commentary
The Persistent Challenge of Peripheral Arterial Calcium
12/22/2025
McCall Walker, MD
In this video, McCall Walker, MD, discusses the article by Finn et al, "Dealing With Dense Calcium".
In this video, McCall Walker, MD, discusses the article by Finn et al, "Dealing With Dense Calcium".
In this video, McCall Walker,...
12/22/2025
Vascular Disease Management
Dr Nagarsheth
Sponsored Video
“Artix handles the complexity we see in real arterial cases.”
12/01/2025
Khanjan Nagarsheth, MD, MBA, RPVI
Dr KJ Nagarsheth, Professor of Surgery, Division of Vascular Surgery, at the University of Maryland School of Medicine, offers a concise, real-world readout on the clinical and procedural value of the Artix thrombectomy system.
Dr KJ Nagarsheth, Professor of Surgery, Division of Vascular Surgery, at the University of Maryland School of Medicine, offers a concise, real-world readout on the clinical and procedural value of the Artix thrombectomy system.
Dr KJ Nagarsheth, Professor of...
12/01/2025
Vascular Disease Management
Stumetz headshot
CIO 2025
Absorbable Gelatin Hydrodissection in Oncologic Thermal Ablations: Initial Outcomes
11/25/2025
Kyle S. Stumetz, DO; Laura Simson, MA
Kyle S. Stumetz, winner of the 2025 CIO Young Investigator Award, discusses his study, “Absorbable Gelatin Hydrodissection in Oncologic Thermal Ablations: Initial Outcomes.”
Kyle S. Stumetz, winner of the 2025 CIO Young Investigator Award, discusses his study, “Absorbable Gelatin Hydrodissection in Oncologic Thermal Ablations: Initial Outcomes.”
Kyle S. Stumetz, winner of the...
11/25/2025
Vascular Disease Management
Video Commentary
Chronic Limb-Threatening Ischemia: Changing the Present Algorithm of Evaluation and Therapy
11/20/2025
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
In this video, Dr Walker discusses the article by Zarins and Krievens, "Chronic Limb-Threatening Ischemia: Are We Saving Limbs but Losing Lives?"
In this video, Dr Walker discusses the article by Zarins and Krievens, "Chronic Limb-Threatening Ischemia: Are We Saving Limbs but Losing Lives?"
In this video, Dr Walker...
11/20/2025
Vascular Disease Management

Presentations

Dr Elizabeth Genovese
ISET 2026
When Do I Think of a Bypass? Reframing Revascularization Decisions in CLTI
02/11/2026
Elizabeth Genovese, MD, MS, FACS, RPVI
Dr Elizabeth Genovese asked a nuanced question regarding patients with CLTI: when should bypass be considered first—and why?
Dr Elizabeth Genovese asked a nuanced question regarding patients with CLTI: when should bypass be considered first—and why?
Dr Elizabeth Genovese asked a...
02/11/2026
Vascular Disease Management
John Rundback MD
ISET 2026
Vessel Preparation for Tibial Interventions: Why “Just PTA” Is Rarely Enough
02/11/2026
John H. Rundback, MD, FAHA, FSIR
Dr. John H. Rundback challenges the long-standing notion that plain balloon angioplasty alone is sufficient for tibial interventions in patients with chronic limb-threatening ischemia .
Dr. John H. Rundback challenges the long-standing notion that plain balloon angioplasty alone is sufficient for tibial interventions in patients with chronic limb-threatening ischemia .
Dr. John H. Rundback challenges...
02/11/2026
Vascular Disease Management
Dr Andrew Holden
ISET 2026
Bioresorbable Scaffolds in BTK Disease: Where We Are and Where We’re Headed
02/10/2026
Andrew Holden, MBChB
Dr Andrew Holden delivered a comprehensive and forward-looking overview of bioresorbable scaffold technology for BTK disease, with a particular focus on CLTI.
Dr Andrew Holden delivered a comprehensive and forward-looking overview of bioresorbable scaffold technology for BTK disease, with a particular focus on CLTI.
Dr Andrew Holden delivered a...
02/10/2026
Vascular Disease Management
Francesco Liistro, MD
LINC 2026
How to Optimize DCB Results in BTK Arteries: ‘Deep Drug Delivery Is Key!’
01/29/2026
Francesco Liistro, MD
Dr Francesco Liistro shares a pragmatic, mechanics-first approach to DCB therapy in BTK arteries.
Dr Francesco Liistro shares a pragmatic, mechanics-first approach to DCB therapy in BTK arteries.
Dr Francesco Liistro shares a...
01/29/2026
Vascular Disease Management
Dr Tatsuya Nakama
LINC 2026
First-Time Data Revealed From Three-Year PROSPECT MONSTER DCB Registry
01/29/2026
Tatsuya Nakama, MD
Dr Tatsuya Nakama discusses how device design, paclitaxel dose, and meticulous lesion preparation may shape long-term durability in everyday practice.
Dr Tatsuya Nakama discusses how device design, paclitaxel dose, and meticulous lesion preparation may shape long-term durability in everyday practice.
Dr Tatsuya Nakama discusses how...
01/29/2026
Vascular Disease Management
Dr Koen Deloose
LINC 2026
SEPARATE: Could Novel Impedance Sensor be the Best Way to Differentiate Clots in PAD?
01/28/2026
Koen Deloose, MD
An introduction to the SEPARATE feasibility clinical study of the Clotild Smart Guidewire System (Sensome) in peripheral artery disease was presented at LINC on Tuesday afternoon by Dr Koen Deloose.
An introduction to the SEPARATE feasibility clinical study of the Clotild Smart Guidewire System (Sensome) in peripheral artery disease was presented at LINC on Tuesday afternoon by Dr Koen Deloose.
An introduction to the SEPARATE...
01/28/2026
Vascular Disease Management
Dr Brodmann
AMP 2025
Transradial Access Shifts the Paradigm in Treating Chronic Limb-Threatening Ischemia
08/14/2025
Marianne Brodmann, MD
Marianne Brodmann, MD, delivered a detailed update on how she employs radial artery access to manage chronic limb-threatening ischemia.
Marianne Brodmann, MD, delivered a detailed update on how she employs radial artery access to manage chronic limb-threatening ischemia.
Marianne Brodmann, MD, delivered...
08/14/2025
Vascular Disease Management
Dr Pliagas
AMP 2025
How IVUS Changed My Intervention
08/14/2025
George Pliagas, MD, FACS, FRCSC
During Thursday’s “Diagnosis and Imaging in CLTI” session, George Pliagas, MD, FACS, FRCSC, shared how IVUS has reshaped his approach to treating peripheral vascular disease.
During Thursday’s “Diagnosis and Imaging in CLTI” session, George Pliagas, MD, FACS, FRCSC, shared how IVUS has reshaped his approach to treating peripheral vascular disease.
During Thursday’s “Diagnosis and...
08/14/2025
Vascular Disease Management
Dr Tokuda
AMP 2025
Atherectomy + DCB vs Stent-Based Repair for Severely Calcified Femoropopliteal Disease
08/13/2025
Takahiro Tokuda, MD
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Vascular surgeon Dr. Takahiro...
08/13/2025
Vascular Disease Management
Dr Zeller
AMP 2025
WOUNDSinCLTI Trial Update: Pathogen-Driven Insights Into Limb Salvage in CLTI
08/13/2025
Thomas Zeller, MD, PhD
Thomas Zeller, MD, from the Universitaets-Herzzentrum Freiburg, Bad Krozingen, Germany, presented the inaugural findings from the WOUND infection and clinical outcomeS IN patients with Chronic Limb-Threatening Ischemia (WOUNDSinCLTI) study,
Thomas Zeller, MD, from the Universitaets-Herzzentrum Freiburg, Bad Krozingen, Germany, presented the inaugural findings from the WOUND infection and clinical outcomeS IN patients with Chronic Limb-Threatening Ischemia (WOUNDSinCLTI) study,
Thomas Zeller, MD, from the...
08/13/2025
Vascular Disease Management
Dr Mike Watts
ISET 2026
How I Do It: Distal Deep Venous Arterialization in the OBL
02/11/2026
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from...
02/11/2026
Vascular Disease Management
Dr Elizabeth Genovese
ISET 2026
When Do I Think of a Bypass? Reframing Revascularization Decisions in CLTI
02/11/2026
Elizabeth Genovese, MD, MS, FACS, RPVI
Dr Elizabeth Genovese asked a nuanced question regarding patients with CLTI: when should bypass be considered first—and why?
Dr Elizabeth Genovese asked a nuanced question regarding patients with CLTI: when should bypass be considered first—and why?
Dr Elizabeth Genovese asked a...
02/11/2026
Vascular Disease Management
Dr William Kuo
ISET 2026
Clot Management in the IVC: Matching the Device to the Disease
02/11/2026
William T. Kuo, MD
During a Wednesday afternoon session at ISET 2026, Sr William Kuo walked attendees through a practical, case-based approach to managing inferior vena cava thrombosis.
During a Wednesday afternoon session at ISET 2026, Sr William Kuo walked attendees through a practical, case-based approach to managing inferior vena cava thrombosis.
During a Wednesday afternoon...
02/11/2026
Vascular Disease Management
John Rundback MD
ISET 2026
Vessel Preparation for Tibial Interventions: Why “Just PTA” Is Rarely Enough
02/11/2026
John H. Rundback, MD, FAHA, FSIR
Dr. John H. Rundback challenges the long-standing notion that plain balloon angioplasty alone is sufficient for tibial interventions in patients with chronic limb-threatening ischemia .
Dr. John H. Rundback challenges the long-standing notion that plain balloon angioplasty alone is sufficient for tibial interventions in patients with chronic limb-threatening ischemia .
Dr. John H. Rundback challenges...
02/11/2026
Vascular Disease Management
John Fritz Angle, MD
ISET 2026
AVM Embolization Strategies: Tools and Tactics That Work
02/10/2026
John Fritz Angle, MD
Interventional radiologist John Fritz Angle, MD, walked attendees through the evolving landscape of arteriovenous malformation (AVM) embolization.
Interventional radiologist John Fritz Angle, MD, walked attendees through the evolving landscape of arteriovenous malformation (AVM) embolization.
Interventional radiologist John...
02/10/2026
Vascular Disease Management
Sean P. Lyden, MD
ISET 2026
Real-World Acute Limb Ischemia: What the PROWL Registry Is Teaching Us
02/10/2026
Sean P. Lyden, MD
Sean P. Lyden, MD, discussed new real-world data from the PROWL Registry, offering a look at how acute, subacute, and CLTI are being treated outside the confines of traditional clinical trial exclusions.
Sean P. Lyden, MD, discussed new real-world data from the PROWL Registry, offering a look at how acute, subacute, and CLTI are being treated outside the confines of traditional clinical trial exclusions.
Sean P. Lyden, MD, discussed new...
02/10/2026
Vascular Disease Management
Dr Andrew Holden
ISET 2026
Bioresorbable Scaffolds in BTK Disease: Where We Are and Where We’re Headed
02/10/2026
Andrew Holden, MBChB
Dr Andrew Holden delivered a comprehensive and forward-looking overview of bioresorbable scaffold technology for BTK disease, with a particular focus on CLTI.
Dr Andrew Holden delivered a comprehensive and forward-looking overview of bioresorbable scaffold technology for BTK disease, with a particular focus on CLTI.
Dr Andrew Holden delivered a...
02/10/2026
Vascular Disease Management
Ripal T. Gandhi, MD
ISET 2026
Single-Use Handheld Vascular Robotics: What Is the Future?
02/10/2026
Ripal T. Gandhi, MD, FSIR, FSVM
Ripal T. Gandhi, MD, FSIR, FSVM, explored how single-use, handheld robotic systems could shape the next phase of peripheral endovascular intervention.
Ripal T. Gandhi, MD, FSIR, FSVM, explored how single-use, handheld robotic systems could shape the next phase of peripheral endovascular intervention.
Ripal T. Gandhi, MD, FSIR, FSVM,...
02/10/2026
Vascular Disease Management
James F. Meschia, MD
ISET 2026
Redefining Optimal Medical Therapy in Carotid Disease: Key Lessons from CREST-2
02/09/2026
James F. Meschia, MD
James F. Meschia, MD, provides an overview of what “optimal medical therapy” means in contemporary carotid disease management.
James F. Meschia, MD, provides an overview of what “optimal medical therapy” means in contemporary carotid disease management.
James F. Meschia, MD, provides...
02/09/2026
Vascular Disease Management
Nicos Labropoulos, MD
ISET 2026
Beyond Stenosis: Identifying the Truly High-Risk Carotid Plaque
02/09/2026
Nicos Labropoulos, MD
Nicos Labropoulos, MD, presented an overview of what defines a “high-risk” carotid plaque and why relying on luminal stenosis alone is no longer enough.
Nicos Labropoulos, MD, presented an overview of what defines a “high-risk” carotid plaque and why relying on luminal stenosis alone is no longer enough.
Nicos Labropoulos, MD, presented...
02/09/2026
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Peripheral Arterial Disease
CIS and Terrebonne General Are First in Louisiana to Use the AngioSafe Santreva™-ATK Endovascular Revascularization Catheter
01/09/2026
JANUARY 8, 2026 –HOUMA, LA – Cardiovascular Institute of the South (CIS) and Terrebonne General Health System (Terrebonne General) are the first in Louisiana to use the AngioSafe Santreva™-ATK Endovascular Revascularization Catheter to...
JANUARY 8, 2026 –HOUMA, LA – Cardiovascular Institute of the South (CIS) and Terrebonne General Health System (Terrebonne General) are the first in Louisiana to use the AngioSafe Santreva™-ATK Endovascular Revascularization Catheter to...
JANUARY 8, 2026 –HOUMA, LA...
01/09/2026
Vascular Disease Management
intravascular lithotripsy
FastWave Medical Names Leading Vascular Specialists as Principal Investigators for Peripheral IVL Trial
10/02/2025
The study will evaluate the safety and effectiveness of the Artero™ IVL system in treating peripheral arterial disease (PAD) and support FastWave's ultimate path to FDA clearance.
The study will evaluate the safety and effectiveness of the Artero™ IVL system in treating peripheral arterial disease (PAD) and support FastWave's ultimate path to FDA clearance.
The study will evaluate the...
10/02/2025
Vascular Disease Management
Retrievable Stents
CIS and Terrebonne General are First in Louisiana to Use the Spur® Peripheral Retrievable Stent System to Treat Artery Disease Below the Knee
06/16/2025
JUNE 16, 2025 – HOUMA, LA – Cardiovascular Institute of the South (CIS) and Terrebonne General Health System (Terrebonne General) are the first in Louisiana to use the Spur® Peripheral Retrievable Stent System to treat chronic...
JUNE 16, 2025 – HOUMA, LA – Cardiovascular Institute of the South (CIS) and Terrebonne General Health System (Terrebonne General) are the first in Louisiana to use the Spur® Peripheral Retrievable Stent System to treat chronic...
JUNE 16, 2025 – HOUMA, LA –...
06/16/2025
Vascular Disease Management
VAM25
New Study Finds GLP-1 Medications Decrease Risk of Major Cardiovascular Events and Amputations for Patients With Moderate Peripheral Artery Disease
06/06/2025
NEW ORLEANS, LA, JUNE 6, 2025 – A large retrospective review of over 100,000 patients found the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in moderate peripheral artery disease (PAD) is associated with a decreased rate of...
NEW ORLEANS, LA, JUNE 6, 2025 – A large retrospective review of over 100,000 patients found the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in moderate peripheral artery disease (PAD) is associated with a decreased rate of...
NEW ORLEANS, LA, JUNE 6, 2025 –...
06/06/2025
Vascular Disease Management
Drug-Coated Balloons
Cardiovascular Institute of the South Is First in the World to Use New Drug-Coated Balloon to Treat Leg Artery Blockages
05/27/2025
May 24, 2024 – Lafayette, LA – Cardiovascular Institute of the South (CIS) is the first in the world to use the 200-cm RANGER Drug-Coated Balloon to treat peripheral artery disease (PAD) in the legs. CIS interventional cardiologist Dr....
May 24, 2024 – Lafayette, LA – Cardiovascular Institute of the South (CIS) is the first in the world to use the 200-cm RANGER Drug-Coated Balloon to treat peripheral artery disease (PAD) in the legs. CIS interventional cardiologist Dr....
May 24, 2024 – Lafayette,...
05/27/2025
Vascular Disease Management
Lower-extremity intervention
First Patient Treated in ELITE-BTK Pivotal Trial for Below-the-Knee PAD Using R3 Vascular's Magnitude Drug-Eluting Bioresorbable Scaffold
04/22/2025
The first patient in its ELITE-BTK pivotal trial was treated by Dr. Brian DeRubertis, FACS, Chief of the Division of Vascular & Endovascular Surgery at NewYork-Presbyterian and Weill Cornell Medicine in New York City.
The first patient in its ELITE-BTK pivotal trial was treated by Dr. Brian DeRubertis, FACS, Chief of the Division of Vascular & Endovascular Surgery at NewYork-Presbyterian and Weill Cornell Medicine in New York City.
The first patient in its...
04/22/2025
Cath Lab Digest
Restenosis
Real-world Data Shows Cook’s Zilver PTX Leads to Lower Rates of In-stent Occlusion Than Boston Scientific’s Eluvia
03/27/2025
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook...
03/27/2025
Vascular Disease Management
Critical Limb Ischemia
AngioDynamics Initiates AMBITION BTK RCT and Registry to Advance Treatment for Critical Limb Ischemia
01/30/2025
The Auryon laser can be used to treat all infrainguinal lesion types, including above-the-knee (ATK), below-the-knee (BTK) and In-Stent Restenosis (ISR)3-6 and to date, it has been used to treat more than 100,000 patients7 in the United...
The Auryon laser can be used to treat all infrainguinal lesion types, including above-the-knee (ATK), below-the-knee (BTK) and In-Stent Restenosis (ISR)3-6 and to date, it has been used to treat more than 100,000 patients7 in the United...
The Auryon laser can be used to...
01/30/2025
Vascular Disease Management
Bioresorbable Scaffolds
R3 Vascular Secures WCG IRB Approval and CMS Category B Medicare Coverage for the ELITE-BTK Pivotal Trial of its MAGNITUDE Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
01/13/2025
Eric A. Secemsky, MD, MSc, lead investigator for the ELITE-BTK pivotal trial, said, “R3 Vascular’s novel approach in the design of its next generation bioresorbable drug eluting scaffold is of great interest to the physician community and has...
Eric A. Secemsky, MD, MSc, lead investigator for the ELITE-BTK pivotal trial, said, “R3 Vascular’s novel approach in the design of its next generation bioresorbable drug eluting scaffold is of great interest to the physician community and has...
Eric A. Secemsky, MD, MSc, lead...
01/13/2025
Vascular Disease Management
Clot-Sensing Guidewire
Sensome Announces Data From Two New Studies Showing Clot-Sensing Guidewire Successfully Identifies Fresh Clot to Support Decision-Making in Peripheral Artery Disease Treatment
12/13/2024
Data showcased in two late-breaking clinical trial presentations at Paris Vascular Insights Course PARIS – December 13, 2024 – Sensome, the pioneer of microsensing technology for instant intra-operative tissue analysis, today announced...
Data showcased in two late-breaking clinical trial presentations at Paris Vascular Insights Course PARIS – December 13, 2024 – Sensome, the pioneer of microsensing technology for instant intra-operative tissue analysis, today announced...
Data showcased in two...
12/13/2024
Vascular Disease Management
Endovascular Devices
Thrombolex, Inc. Secures $50 Million Series A Growth Financing to Advance Commercialization of its Innovative Pharmaco-Mechanical Lysis Technology (PML)
03/19/2026
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, March 16, 2026...
03/19/2026
Vascular Disease Management
Neurovascular Care
Medtronic to Acquire Scientia Vascular, Marrying Access and Therapeutic Portfolios for Neurovascular Care
03/10/2026
Deal complements Medtronic's Neurovascular portfolio, delivering simplicity and access when 'time is brain'.
Deal complements Medtronic's Neurovascular portfolio, delivering simplicity and access when 'time is brain'.
Deal complements Medtronic's...
03/10/2026
Vascular Disease Management
VDM logo
Analysis
Artificial Intelligence Advances in Interventional Oncology: Year in Review
02/23/2026
Laura Simson, MA
02/23/2026
Vascular Disease Management
New Stroke Guidelines
New Guideline Expands Stroke Treatment for Adults, Offers First Pediatric Stroke Guidance
02/19/2026
Updated ischemic stroke recommendations from the American Stroke Association highlight how rapid diagnosis and imaging, extended time windows for stroke treatments and coordinated care involving emergency services, hospitals and health care...
Updated ischemic stroke recommendations from the American Stroke Association highlight how rapid diagnosis and imaging, extended time windows for stroke treatments and coordinated care involving emergency services, hospitals and health care...
Updated ischemic stroke...
02/19/2026
Vascular Disease Management
Radiation Safety
RAMPART Appoints Rob Williamson as Chief Revenue Officer
02/12/2026
BIRMINGHAM, Ala. — February 12, 2026 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional radiation safety, today announced that Rob Williamson has been appointed Chief Revenue Officer (CRO), efective March...
BIRMINGHAM, Ala. — February 12, 2026 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional radiation safety, today announced that Rob Williamson has been appointed Chief Revenue Officer (CRO), efective March...
BIRMINGHAM, Ala. — February 12,...
02/12/2026
Vascular Disease Management
The Salus and Tallahassee Memorial HealthCare teams celebrate after the first AeroShield case.
Radiation Protection Systems
Tallahassee Memorial HealthCare Advances Cath Lab Safety Through First-in-the-World Technology Adoption
02/10/2026
Salus Scientific and Tallahassee Memorial HealthCare (TMH) announced the successful implementation and first clinical use of AeroShield™, a groundbreaking radiation protection technology developed by Salus Scientific.
Salus Scientific and Tallahassee Memorial HealthCare (TMH) announced the successful implementation and first clinical use of AeroShield™, a groundbreaking radiation protection technology developed by Salus Scientific.
Salus Scientific and Tallahassee...
02/10/2026
Cath Lab Digest
Embolic Device
Fluidx Embolic IDE Trial Results Accepted for Late-Breaking Presentation at the SIR Annual Meeting
02/10/2026
Fluidx Medical Technology, Inc. is a clinical-stage medical device company advancing its next-generation gel embolic technology.
Fluidx Medical Technology, Inc. is a clinical-stage medical device company advancing its next-generation gel embolic technology.
Fluidx Medical Technology, Inc....
02/10/2026
Vascular Disease Management
Thrombectomy
Avantec Vascular, a NIPRO Company, Announces FDA 510(k) Clearance of Thrombectomy System
02/10/2026
Sunnyvale, California – Avantec Vascular, a NIPRO Company, has received FDA 510(k) clearance for a thrombectomy system that will enable a new type of treatment for patients with thrombus in the peripheral venous...
Sunnyvale, California – Avantec Vascular, a NIPRO Company, has received FDA 510(k) clearance for a thrombectomy system that will enable a new type of treatment for patients with thrombus in the peripheral venous...
Sunnyvale, California...
02/10/2026
Cath Lab Digest
News
RAMPART Appoints Former Thoratec CEO Gary Burbach as Chairman of the Board
02/04/2026
BIRMINGHAM, Ala. — February 4, 2026 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional radiation safety, today announced the appointment of Gerhard (Gary) F. Burbach as Chairman of its Board of...
BIRMINGHAM, Ala. — February 4, 2026 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional radiation safety, today announced the appointment of Gerhard (Gary) F. Burbach as Chairman of its Board of...
BIRMINGHAM, Ala. — February 4,...
02/04/2026
Vascular Disease Management
Cardiovascular Scientific Forum
AngioDynamics to Convene Cardiovascular Leaders at Scientific Forum as Pipeline Continues to Advance
02/03/2026
Physician-led Collaboration Reinforces Ongoing Regulatory Activity and Clinical Advancement Across the Cardiovascular Portfolio LATHAM, N.Y.--Feb. 3, 2026-- AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on...
Physician-led Collaboration Reinforces Ongoing Regulatory Activity and Clinical Advancement Across the Cardiovascular Portfolio LATHAM, N.Y.--Feb. 3, 2026-- AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on...
Physician-led Collaboration...
02/03/2026
Vascular Disease Management

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use